HRMY
Harmony Biosciences Holdings, Inc.
NASDAQ · Healthcare · Biotechnology · US
$42.25
+0.93%Forward multiples
Based on analyst estimates
- P/E forward
- 10.55x
- P/E 2026E
- 10.67x
- P/E 2027E
- 9.83x
- P/E 2028E
- 8.71x
- P/S forward
- 2.22x
Trailing multiples
Trailing twelve months
- P/E TTM
- 13.50x
- PEG TTM
- 0.48x
- Price / book
- 2.46x
- Price / sales
- 2.56x
- Price / cash flow
- 6.93x
Enterprise value
- Enterprise value
- $1.9B
- EV / sales
- 2.03x
- EV / EBITDA
- 7.04x
- EV / EBIT
- 8.44x
- Market cap
- $2.5B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026